LTX-315 is an oncolytic peptide with potent anticancer activity; inhibits MRC-5, A20 and AT84 with IC50s of 34.3, 8.3 and 11 μM, respectively.
CAT No: R1491
CAS No:1345407-05-7
Synonyms/Alias:LTX-315;1345407-05-7;Oncopore;Ruxotemitide;Kkwwkkwdipk-nh2;ruxotemitida;Kkwwkkw-.beta.-phenyl-fk-nh2;LTX 315;RUXOTEMITIDE [INN];UNII-75FBL12IZ7;75FBL12IZ7;(S)-2,6-diamino-N-((5S,8S,11S,14S,17S,20S,23S,26S)-11,20,23-tris((1H-indol-3-yl)methyl)-1,30-diamino-14,17-bis(4-aminobutyl)-8-benzhydryl-5-carbamoyl-7,10,13,16,19,22,25-heptaoxo-6,9,12,15,18,21,24-heptaazatriacontan-26-yl)hexanamide;L-LYSINAMIDE, L-LYSYL-L-LYSYL-L-TRYPTOPHYL-L-TRYPTOPHYL-L-LYSYL-L-LYSYL-L-TRYPTOPHYL-.BETA.-PHENYL-L-PHENYLALANYL-;ruxotemitidum;CHEMBL4297628;LTX 315 [WHO-DD];KKWWKKW-BETA-PHENYL-FK-NH2;s8199;AKOS032945178;CCG-270681;CS-6979;DB12748;BS-15278;DA-65090;HY-19894;D84062;Q27266383;(2S)-6-AMINO-2-[(2S)-2-[(2S)-2-[(2S)-6-AMINO-2-[(2S)-6-AMINO-2-[(2S)-2-[(2S)-2-[(2S)-6-AMINO-2-[(2S)-2,6-DIAMINOHEXANAMIDO]HEXANAMIDO]-3-(1H-INDOL-3-YL)PROPANAMIDO]-3-(1H-INDOL-3-YL)PROPANAMIDO]HEXANAMIDO]HEXANAMIDO]-3-(1H-INDOL-3-YL)PROPANAMIDO]-3,3-DIPHENYLPROPANAMIDO]HEXANAMIDE;L-LYSINAMIDE, L-LYSYL-L-LYSYL-L-TRYPTOPHYL-L-TRYPTOPHYL-L-LYSYL-L-LYSYL-L-TRYPTOPHYL-BETA-PHENYL-L-PHENYLALANYL-;
1. Emu oil in combination with other active ingredients for treating skin imperfections
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.